|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:455-464
© 2003 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Department of Biomedical Engineering, Fukuoka, Japan
b Department of Cardiac Surgery, Graduate School of Medicine, Kyushu University, Fukuoka, Japan
c Department of Bioengineering, National Cardiovascular Center Research Institute, Osaka, Japan
Received for publication March 22, 2002; revisions received May 16, 2002; revisions received May 29, 2002; accepted for publication July 26, 2002.
* Address for reprints: Takehisa Matsuda, MD, Department of Biomedical Engineering, Graduate School of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku grbf, Fukuoka 812-8582, Japan
matsuda{at}med.kyushu-u.ac.jp
OBJECTIVE: We sought to fabricate a compliant engineered vascular graft (inner diameter of approximately 4.5 mm and length of 6 cm) lined with endothelial progenitor cells derived from circulating peripheral canine blood and to verify its nonthrombogenicity potential in vivo.
METHODS: Autologous circulating endothelial progenitor cells derived from the peripheral veins of 6 adult mongrel dogs were isolated by using a density gradient method. The cells were proliferated in vitro in EGM-2 culture medium, prelined on the luminal surface of in situformed collagen type I meshes as an extracellular matrix, and wrapped with a segmented polyurethane thin film with multiple micropores as a compliant scaffold. After canine carotid arteries were bilaterally implanted with these grafts for 1 and 3 months, microscopic observation, histologic staining, and immunochemical staining were performed to evaluate morphogenesis.
RESULTS: After 33.3 ± 10.5 days of culture in vitro, 4.2 ± 1.2 x 106 endothelial progenitor cells were obtained. Eleven of the 12 engineered vascular grafts were patent. The grafts possessed smooth, glistening, and ivory-colored luminal surfaces at the predetermined observation period up to 3 months. The intimal layer was covered with confluent, cobblestone-like monolayered cells that were positively stained with factor VIIIBrelated antigen. The thickness of the neoarterial walls was approximately 300 µm at 3 months after implantation. A few smooth muscle cells were observed in the medial tissue, and fibroblasts dominated the adventitial tissue.
CONCLUSION: Circulating endothelial progenitor cells could be a substitute source of endothelial cells for endothelialization on small-diameter-vessel prostheses to ensure nonthrombogenicity.
This article has been cited by other articles:
![]() |
K. Torikai, H. Ichikawa, K. Hirakawa, G. Matsumiya, T. Kuratani, S. Iwai, A. Saito, N. Kawaguchi, N. Matsuura, and Y. Sawa A self-renewing, tissue-engineered vascular graft for arterial reconstruction J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 37 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roy-Chaudhury Endothelial Progenitor Cells, Neointimal Hyperplasia, and Hemodialysis Vascular Access Dysfunction: Novel Therapies for a Recalcitrant Clinical Problem Circulation, July 5, 2005; 112(1): 3 - 5. [Full Text] [PDF] |
||||
![]() |
M. R. Hoenig, G. R. Campbell, B. E. Rolfe, and J. H. Campbell Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts? Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |